US FDA Shies Away From Zoom Meetings Because Of Security Concerns
Uninvited guests already have accessed virtual meetings with sponsors using the application, raising concerns about the protection of proprietary information.
You may also be interested in...
Scott Gottlieb says that some meetings should remain in-person, but with virtual options proven effective, the FDA could offer more opportunities to talk to sponsors.
Sponsors will receive additional agency interactions through the formal meeting process, as well as an option to ask clarifying questions later.
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.